MedCool

MedCool was a medical device company specializing in the development of therapeutic hypothermia systems for targeted temperature management. The company's primary technology focused on non-invasive, rapid cooling of the brain to provide neuroprotection for patients suffering from stroke, cardiac arrest, or traumatic brain injury. Its core product utilized an intranasal cooling method designed to achieve faster induction of hypothermia compared to traditional systemic cooling techniques. MedCool's solutions were intended for use in both emergency pre-hospital settings and intensive care units to mitigate neurological damage. In 2014, the company's intellectual property and assets were acquired by the Swedish medical technology firm BrainCool AB, which integrated the technology into its own portfolio of cooling therapies.